GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » EPS (Basic)

Aarey Drugs & Pharmaceuticals (BOM:524412) EPS (Basic) : ₹1.14 (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals EPS (Basic)?

Aarey Drugs & Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was ₹0.75. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.14.

Aarey Drugs & Pharmaceuticals's EPS (Diluted) for the three months ended in Dec. 2023 was ₹0.75. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.14.

Aarey Drugs & Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2023 was ₹0.75. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 1.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Aarey Drugs & Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals EPS (Basic) Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.80 2.48 2.79 2.72 1.49

Aarey Drugs & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 -0.21 0.29 0.31 0.75

Aarey Drugs & Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aarey Drugs & Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2023 is calculated as

Basic EPS (A: Mar. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(37.711-0)/25.385
=1.49

Aarey Drugs & Pharmaceuticals's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(19.079-0)/25.385
=0.75

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarey Drugs & Pharmaceuticals  (BOM:524412) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Aarey Drugs & Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarey Drugs & Pharmaceuticals (BOM:524412) Business Description

Traded in Other Exchanges
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (BOM:524412) Headlines

No Headlines